期刊文献+

HPV感染、HIF-1α及VEGF蛋白表达与非小细胞肺癌相关 被引量:1

Infection of HPV and its relationship with the expression of HIF-1α and VEGF protein in non-small cell lung cancer
下载PDF
导出
摘要 目的探讨人乳头状瘤病毒(HPV)感染在非小细胞肺癌(NSCLC)发生中的病因学意义,并初步分析HPV感染与低氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF)蛋白表达之间的关系。方法用免疫组化法检测60例NSCLC及20例肺良性病变组织中HIF-1α和VEGF蛋白表达,用PCR法选用HPV16、18型特异性引物检测两组中HPV DNA的表达。结果 1)NSCLC组HPV DNA积分吸光度比值为0.6046±0.0224,显著高于肺良性病变组的0.0275±0.1230(P<0.05)。2)NSCLC组HIF-1α和VEGF蛋白的平均吸光度值分别为0.2548±0.0219和0.2051±0.0321,均显著高于肺良性病变组(0.0826±0.0150和0.0726±0.0227)(P<0.05)。3)NSCLC中HIF-1α的表达率与VEGF呈正相关(P<0.05)。4)NSCLC中HPV(+)组VEGF的表达率为56.0%,显著高于HPV(-)组的28.6%(P<0.05)。结论 HPV感染可能是NSCLC发生的病因学因素之一;HPV感染可能通过上调VEGF的表达,促进肺癌的发生发展。 Objective To investigate the etiological role of human papillomavirus (HPV) infection in the carcinogenesis of non-small cell lung cancer(NSCLC) and to discuss the possible relationship between HPV infection and HIF-1 α, VEGF expression. Methods By using immunohistochemistry, the expressions of HIF-1α and VEGF protein were detected in 60 cases of NSCLC tissues and 20 cases of lung benign diseases tissues. PCR was employed to detect the expression of HPV16/18 DNA. Results 1 ) The HPV DNA expression was 0. 6046 ±0. 0224 in NSCLC group which significantly higher than 0. 0275±0. 1230 in the benign diseases group (P 〈0. 05). 2)The HIF-1α protein and VEGF protein expressions were 0. 2548 ±0. 0219 and 0. 2051 ±0. 0321 respectively in NSCLC, significantly higher than that in the benign diseases group (0. 0826±0. 0150 and 0. 0726 ±0. 0227) (P 〈0. 05). 3)The expression rate of HIF-1α was significantly correlated with VEGF in NSCLC (P 〈 0. 05 ). 4)The positive expression rate of VEGF was significantly higher in HPV DNA positive group (56. 0% ) than that in HPV DNA negative group(28. 6%,P 〈 0. 05) in NSCLC. Conclusions HPV infection may be one of the etiological factors in the carcinogenesis of NSCLC. HPV infection increases VEGF expression, promotes the occurrence and development of NSCLC.
出处 《基础医学与临床》 CSCD 北大核心 2014年第8期1065-1070,共6页 Basic and Clinical Medicine
基金 秦皇岛市科技支撑计划(2012023A135)
关键词 非小细胞肺癌 人乳头状瘤病毒 低氧诱导因子-1Α 血管内皮生长因子 nonsmall cell lung cancer human papillomavirus hypoxia inducible factor-1α vascular endothelial growth factor
  • 相关文献

参考文献9

二级参考文献33

  • 1李军,王存良,范清宇,张伟,张明华,尚磊.血管内皮生长因子对骨肉瘤的血管生成及转移预后的影响(英文)[J].中国临床康复,2004,8(20):4103-4105. 被引量:2
  • 2康欣梅,张清媛,佟丹丹,赵文辉.低剂量环磷酰胺联合人参皂甙Rg3抑制小鼠肺癌肿瘤血管生成的实验研究[J].中国中西医结合杂志,2005,25(8):730-733. 被引量:14
  • 3Maxwell PH. The HIF pathway in cancer [ J ]. Semin Cell Dev Biol, 2005, 16(4 -5) :523 -530.
  • 4Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of hypoxia inducible factor-lalpha and-2alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival[ J]. Br J Cancer, 2001, 85 (6) :881 -890.
  • 5Mizokami K, Kakeji Y, Oda S,et al. Clinicopathologic significance of hypoxia-inducible factor-1 alpha overexpression in gastric carcinomas [ J ]. Surg Oncol, 2006, 94 ( 2 ) : 149 - 154.
  • 6Rohwer N, Lobitz S, Daskalow K, et al. HIF-1 alpha determines the metastatic potential of gastric cancer cells[J]. Br J Cancer,2009, 100(5) :772-781.
  • 7Song IS, Wang AG, Yoon SY, et al. Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1 beta, but not HIF-2alpha, in gastric cancer [ J ]. Exp Mol Med, 2009, 41(1):51 -58.
  • 8Hashimoto K, Man S, Xu P, et al. Potent preclinical impact pf metronomic low-dose oral topotecan combined with the antiangtiogenic drug pazopanib for the treatment of ovarian cancer [J]. Mol Cancer Ther, 2010, 9:996-1006.
  • 9Tang TC, Man S, Lee CR, et al. Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma [ J ]. Neoplasia, 2010, 12 : 264 - 274.
  • 10Greenberg JI, Cheresh DA. VEGF as an inhibitor of tumor vessel maturation: implication for cancer therapy [ J ]. Expert Opin Biol Ther, 2009, 9:1347 -1356.

共引文献23

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部